A while back I speculated that there was some connection between Synta and Pfizer after Pfizer reported good news on their breast cancer treatment. It turns out I was wrong, however I just thought about something. Pfizer was in fact going after someone, just a bigger fish. The task now is to find out who is working on a lung cancer treatment, how far along they are and what their budget is.. IMO, it's not why someone wants to partner with Synta, it's why they can't afford to not to based on their R&D budget and deadline. Time to work.